H.C. Wainwright Raises its Price Target on CG Oncology, Inc. (CGON) to $80 and Maintains a Buy Rating [Yahoo! Finance]
CG Oncology GAAP EPS of -$2.08 beats by $0.09, revenue of $4.04M beats by $1.24M [Seeking Alpha]
CG Oncology (CGON) had its price target raised by HC Wainwright from $75.00 to $80.00. They now have a "buy" rating on the stock.
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates [Yahoo! Finance]
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates